Searchable abstracts of presentations at key conferences in endocrinology

ea0050apw1.3 | Tissue Engineering for Regenerative Medicine in Endocrinology | SFEBES2017

3D-Bioprinting coming of age-from cells to organs

Thomas Daniel

Over the past decade, annual spending on pharmaceutical development to treat many endocrinological systems has increased exponentially. At the same time, in spite of these huge sums invested, the average number of drugs being approved for human use has decreased to one in ten. Currently, preclinical studies to test the safety and efficiency of new drugs, use laboratory animals and traditional 2D cell culture models. Neither of these methods are completely accurate reflections ...

ea0050apw1.3 | Tissue Engineering for Regenerative Medicine in Endocrinology | SFEBES2017

3D-Bioprinting coming of age-from cells to organs

Thomas Daniel

Over the past decade, annual spending on pharmaceutical development to treat many endocrinological systems has increased exponentially. At the same time, in spite of these huge sums invested, the average number of drugs being approved for human use has decreased to one in ten. Currently, preclinical studies to test the safety and efficiency of new drugs, use laboratory animals and traditional 2D cell culture models. Neither of these methods are completely accurate reflections ...

ea0084op-04-21 | Oral Session 4: Basic 1 | ETA2022

CRYO-electron microscopy structures of human thyroid peroxidase (TPO) in complex with tpo antibodies

Baker Stuart , Nunez Miguel Ricardo , Thomas Daniel , Powell Michael , Furmaniak Jadwiga , Rees Smith Bernard

Objectives: Thyroid peroxidase (TPO) is a key enzyme in the synthesis of thyroid hormones and is a target for autoimmune responses in autoimmune thyroid disease. TPO autoantibody (TPOAb) binding epitopes have been mapped on the peroxidase domain (POD) and the complement control protein like domain (CCP). This study aimed to solve the molecular structures of TPO bound to TPO antibodies.Methods: An extracellular domain (ECD) of human TPO (amino acids; aa 1...

ea0015p208 | Neuroendocrinology and behaviour | SFEBES2008

Craniopharyngioma: a single institutional experience from South India

Sivan Arul Selvan S , Felix Jebasingh K , Rajaratnam Simon , Thomas Paul V , Thomas Nihal , Mandalam Subramaniam Seshadri , Simon Anna , Chacko Ari George , Vedantam Rajshekhar , Thomas Daniel Roy

Introduction: Craniopharyngiomas constitute 2–5% of all primary CNS neoplasms. We retrospectively analysed the case records of all patients with craniopharyngioma treated in our hospital from 1996 to 2006.Results: One hundred and twenty-seven patients were treated during this period. 65% were male and 35% were female. 50 patients (39%) were <15 yrs of age. The maximum clustering of cases was in the 6–15 yr age group (37%).<p class="abs...